Social Media Press Releases

RSS

Showing Press Releases with Tag: influenza virus

12/27/2005

FDA Approves MedImmune’s State-of-the-Art Influenza Vaccine Manufacturing Facility

» read more
12/12/2005

Preliminary Data from CAIV-T Pivotal Phase 3 Trial Demonstrate Clinical Efficacy Over Flu Shot in Head-to-Head Influenza Study

» read more
12/07/2005

MedImmune Expands Patent Estate for Reverse Genetics with New Rights from Mount Sinai School of Medicine

» read more
10/20/2005

MedImmune Reports 2005 Third Quarter and Nine-Month Financial Results

» read more
9/28/2005

MedImmune to Collaborate With National Institutes of Health to Develop Pandemic Influenza Vaccine

» read more
7/21/2005

MedImmune Reports 2005 Second Quarter and Six-Month Financial Results

» read more
4/21/2005

MedImmune Reports Financial Results for First Quarter 2005

» read more
4/15/2005

MedImmune Begins Dosing in Phase 1 Clinical Trial for Nasally Delivered Vaccine Designed to Help Prevent Common Childhood Respiratory Viral Diseases

» read more
2/03/2005

MedImmune’s Product Sales Surpass $1 Billion for First Time

» read more
1/20/2005

MedImmune Files Investigational New Drug Application for Nasally Delivered RSV/PIV-3 Vaccine

» read more
1/11/2005

MedImmune Updates Investors at JPMorgan Healthcare Conference

» read more